Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 15, 2015 - Issue 4
Submit an article Journal homepage
732
Views
13
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for diffuse large B-cell lymphoma

Patrizia MondelloDepartment of Human Pathology, University of Messina, Via C. Valeria, 98100 Messina, Italy;Lymphoma Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 330, New York, NY 10065, USA
&
Anas YounesLymphoma Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 330, New York, NY 10065, USACorrespondence[email protected]
Pages 439-451 | Published online: 05 Feb 2015

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Wenli Cui, Shutao Zheng, Zebing Liu, Weige Wang, Ying Cai, Rui Bi, Bing Cao & Xiaoyan Zhou. (2017) PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro. OncoTargets and Therapy 10, pages 2239-2247.
Read now
Sylvain Garciaz, Diane Coso, Jean-Marc Schiano de Colella & Réda Bouabdallah. (2016) Lenalidomide for the treatment of B-cell lymphoma. Expert Opinion on Investigational Drugs 25:9, pages 1103-1116.
Read now

Articles from other publishers (11)

Manal Mohamed Saber. (2023) Coexpression of PD-L1/PD-1 with CXCR3/CD36 and IL-19 Increase in Extranodal Lymphoma. Journal of Immunology Research 2023, pages 1-17.
Crossref
Pei Xu, Xiaolin Sun, Xuyan Song, Yaqian Peng, Bin He, Zhengdong Wu & Jianfeng Zhu. (2021) Prognostic value of lymphocyte-to-monocyte ratio and histone methyltransferase G9a histone methyltransferase in patients with double expression lymphoma. Medicine 100:4, pages e24449.
Crossref
Soo Jin Kim, U Ji Kim, Hae Yong Yoo, Yong June Choi & Keon Wook Kang. (2020) Anti-Cancer Effects of CKD-581, a Potent Histone Deacetylase Inhibitor against Diffuse Large B-Cell Lymphoma. International Journal of Molecular Sciences 21:12, pages 4377.
Crossref
Sarah E. M. Herman. (2018) The future of kinase inhibitors for DLBCL?. Blood 131:21, pages 2278-2280.
Crossref
H Ding, K L Peterson, C Correia, B Koh, P A Schneider, G S Nowakowski & S H Kaufmann. (2016) Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells. Leukemia 31:7, pages 1593-1602.
Crossref
John KuruvillaMichael SavonaRachid BazPaul Morten Mau-SorensenNashat GabrailRamiro GarzonRichard StoneMichael WangLynn SavoiePeter MartinIan FlinnMeagan JacobyThaddeus J. Unger, Jean-Richard Saint-Martin, Tami Rashal, Sharon Friedlander, Robert Carlson, Michael Kauffman, Sharon Shacham & Martin Gutierrez. (2017) Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma. Blood 129:24, pages 3175-3183.
Crossref
Valentin Goede. (2017) Marginal zone lymphoma in elderly and geriatric patients. Best Practice & Research Clinical Haematology 30:1-2, pages 158-165.
Crossref
E Van Den Neste, N Schmitz, N Mounier, D Gill, D Linch, M Trneny, R Bouadballah, J Radford, M Bargetzi, V Ribrag, U Dührsen, D Ma, J Briere, C Thieblemont, E Bachy, C H Moskowitz, B Glass & C Gisselbrecht. (2016) Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study. Bone Marrow Transplantation 52:2, pages 216-221.
Crossref
Anas Younes, Jesus G Berdeja, Manish R Patel, Ian Flinn, John F Gerecitano, Sattva S Neelapu, Kevin R Kelly, Amanda R Copeland, Amy Akins, Myles S Clancy, Lucy Gong, Jing Wang, Anna Ma, Jaye L Viner & Yasuhiro Oki. (2016) Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial. The Lancet Oncology 17:5, pages 622-631.
Crossref
Ashley D Staton, Jean L Koff, Qiushi Chen, Turgay Ayer & Christopher R Flowers. (2015) Next-generation prognostic assessment for diffuse large B-cell lymphoma. Future Oncology 11:17, pages 2443-2457.
Crossref
Jonathon B Cohen, David M Kurtz, Ashley D Staton & Christopher R Flowers. (2015) Next-generation surveillance strategies for patients with lymphoma. Future Oncology 11:13, pages 1977-1991.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.